Harmine ameliorates CCl
ALI
Autophagy
CCl(4)
Harmine
Inflammatory
TLR4/NF-κB
p38 MAPK/mTOR
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
01 Feb 2024
01 Feb 2024
Historique:
received:
20
10
2023
revised:
03
01
2024
accepted:
10
01
2024
medline:
3
2
2024
pubmed:
3
2
2024
entrez:
2
2
2024
Statut:
aheadofprint
Résumé
CCl
Identifiants
pubmed: 38306830
pii: S1567-5769(24)00056-0
doi: 10.1016/j.intimp.2024.111538
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
111538Informations de copyright
Copyright © 2024 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.